Pamrevlumab (anti-CTGF)
Pamrevlumab, a recombinant human antibody that binds to connective tissue growth factor (CTGF) has emerged as a potential therapy for idiopathic pulmonary fibrosis (IPF).
Click to purchase the isotype control of
2 Citations
17 Nobel Prize winners
have used Selleck products
Shimon Sakaguchi
Nature Communications 2025;16, Article number:1325
David Baker
Dev Cell 2023;58(20):2163-2180.e9.
Michael Houghton
Cell Chem Biol 2020;27(7):780-792.e5
David Julius
Cell 2017;185-198.e16
Charles M. Rice
Cell 2018;172(3):423-438.e25
Quality Control
Mechanism of Action
| Description |
Pamrevlumab, a recombinant human antibody that binds to connective tissue growth factor (CTGF) has emerged as a potential therapy for idiopathic pulmonary fibrosis (IPF).
|
References |
|---|
Product Details
| CAS No. | 946415-13-0 |
|---|---|
| Isotype | Human IgG1, κ |
| Application | Pamrevlumab (anti-CTGF) |
| Sterility | 0.2 μM filtered |
| Formulation | PBS Buffer, PH 7.4 |
| Storage | Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
Comparison of Clones for
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tech Support
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.